Navigation Links
Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011
Date:7/27/2011

with the year-ago period in North America.

"Continued strong demand for our TrueBeam platform and service contracts led to the order and revenue growth during the quarter," Guertin said. "Our TrueBeam platform for radiotherapy and radiosurgery represented more than 40 percent of all machines ordered during the quarter.  This platform enabled us to gain market share in North America while driving growth in international markets with major wins in Scotland, Norway, and Saudi Arabia."

X-Ray ProductsThird quarter revenues from x-ray tubes and flat panel image detectors for filmless imaging were $121 million, up 18 percent from the year-ago quarter.  Compared to the same period in fiscal year 2010, X-Ray Products' third quarter net orders rose 17 percent to $121 million."Demand for our full range of products remained strong in the third quarter," said Guertin.  "X-ray tubes for CT scanners, mammography, and service replacement tubes grew at a double-digit pace."  The overall growth of X-Ray Products segment continued to be led by its radiographic imaging panels that were introduced last year.

OtherThe company's Other category, which is comprised of the Security and Inspection Products (SIP) business, the Varian Particle Therapy business, and the Ginzton Technology Center, recorded third quarter revenues of $16 million, down 18 percent from the year-ago period.  Net orders in the company's Other category were $17 million, down 12 percent from the year-ago quarter.

Outlook "We continue to estimate that revenues for fiscal year 2011 could grow 10 to 11 percent over the fiscal 2010 total," said Guertin. "We now believe that net earnings per diluted share from continuing operations for the year could grow by about 16 percent to be in the range of $3.42 to $3.45."  

Investor Conference CallVarian Medical Systems is scheduled to conduct its third quarter fiscal year 2011 conference call at 2 p
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... Chief Executive Officer, Doug Godshall , is scheduled ... Conference at 8:30 a.m. EDT on Thursday, August 13, ... at the InterContinental Boston. A live webcast ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of the "MRI Systems Market ... Operational Efficiency, with Growth Driven by Developing Economies" ... Systems Market to 2020 - Focus on Patient ... Developing Economies" discusses the market, competitive landscape, and ...
(Date:8/4/2015)...  Dr. Keesha Ewers of The ... of flibanserin, or what is being touted as ... decreased female sexual desire back several decades. Diminished ... addressing libido as a singular symptom with a ... Photo - http://photos.prnewswire.com/prnh/20150804/254705 ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Conn., Oct. 6 The Hedgeye Risk Management Healthcare team, led ... Conference Call, "Aging of America: Demographics of Demand and Profits in ... long tail of demographics, why 1994-2002 was so good, and why ... device demand, and the outlook for hip, knee, and spine device ...
... Oct. 6 Roxane Laboratories, Inc. announced today ... (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg ... Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. ... for immediate shipment to wholesalers and pharmacies nationwide. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th by ... viable method for encouraging people to lose weight. Specifically the study compared control patients ... loss success, adding a financial incentive to the overall incentive of increased health. According ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, ... Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, ... lives," Dr. Carmona said. "I strongly believe in the mission of the company ...
(Date:8/4/2015)... ... August 04, 2015 , ... One of the nation’s leading experts ... new book, The Pain Antidote , which provides strategies for people who suffer ... Center’s Chronic Pain Treatment Program, wrote the book in conjunction with Katherine Ketcham, an ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... immunizations, especially those entering kindergarten. All required immunizations are covered for members under ... means that children who aren’t caught up with their immunizations may not be ...
(Date:8/4/2015)... Hills, CA (PRWEB) , ... August 04, 2015 ... ... personal consultation complete with full examination now offered by the world renowned ... more beautiful aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
... According to the findings of a UCSF study to ... journal "Obstetrics and Gynecology," the risk of miscarriage in ... // or chromosomal abnormalities is lower than previously believed. ... common prenatal tests performed during the first and second ...
... a person grows old, the functioning of his lungs weakens. According ... ,An 8-year study was conducted on 670 men, 45 – 86 ... of long-standing anger at the beginning of the project had notably ... study is one of the first to show prospectively that hostility ...
... turn out to be the worst enemy for asthmatic ... response to air pollution says a recent study.// This ... chronic cough, phlegm production (bronchitis) and dog & cat ... preventive medicine at the University of Southern California's Keck ...
... colon polyps to half, it doubles the risk of serious ... studies published in the Aug. 31 issue of The New ... M.D., Ph.D., and John D. Potter, M.B., Ph.D., of the ... ,"These two trials provide strong evidence that among patients ...
... Physical activity after a high-fat meal not only reverses the ... //of these same arteries compared to before the meal, according ... in the European Journal of Applied Physiology, are part of ... body after the meal -- also known as the postprandial ...
... brain areas preoperative brain could effectively alter the outcome ... appear in the September issue of Radiology, states that ... the brain with functional magnetic resonance imaging (fMRI), could ... effectively, and could also reduce the risk of damaging ...
Cached Medicine News:Health News:Prenatal Test and Miscarriage 2Health News:Prenatal Test and Miscarriage 3Health News:Dogs aggravate asthma in kids 2Health News:Celebrex- pros and cons 2Health News:A Serving of Exercise After That Saturated Fat 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 3
Inquire...
Inquire...
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... APTT-based kit for the screening of factor-V-related ... of the test for the factor V:Q506 ... plasma with an excess of V-DEF Plasma ... to discriminate between heterozygous and homozygous factor ...
Medicine Products: